Merck & Co. Inc. (MRK)
Trading Center
Loading...
Symbols:
MRK Forum Topics
- All Comments on MRK
- General Discussion on MRK
- Why I'm Buying Amylin Now [view article]
- Dow Price Targets from Last November [view article]
- Merck’s Gardasil: A Risky and Unnecessary Vaccine [view article]
- The Top Dividend Paying ETFs and Stocks [view article]
- Biotech Day in Review: Hopeful Results from HIV Conference [view article]
- Looking Inside the New Ben Graham ETN Baskets [view article]
- Time to Invest in Pharmaceuticals? [view article]
- How Have 'Traditional Defensive Stocks' Done in This Downturn? [view article]
- 5 Potential Buyout Targets in Biotech - Barron's [view article]
- Dow 30 Trading Ranges [view article]
- HPC Vaccine Inspires Yellow Health Journalism [view article]
- Dow 30 Performance Since 7/15 [view article]
Recent MRK Articles
- Dow Price Targets from Last November
- Merck’s Gardasil: A Risky and Unnecessary Vaccine
- Why I'm Buying Amylin Now
- Looking Inside the New Ben Graham ETN Baskets
- Time to Invest in Pharmaceuticals?
- 5 Potential Buyout Targets in Biotech - Barron's
- How Have 'Traditional Defensive Stocks' Done in This Downturn?
- Dow 30 Trading Ranges
- $120 Oil's Struggle with the Dow Industrials
- The Case Against Investing in the Dow Industrials (For Now)
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
Going Schluming - Cramer's Lightning Round (4.11.08) [view article]
Very credible advice from a guy that owns Mastercard !At least we know who Cramer is and what he is, unlike so many of the mystery authors of seeking alpha 'commentary' who seem unwilling to post resumes. Reply
Merck, Schering-Plough: Confessions of a Vytorin Patient [view article]
You made a good point, bmc.There are some fundamental assumptions that need to be questioned.
Until then, moving from Vytorin to Zocor makes no sense at all. Reply
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
Iknowjack, you don't seem to understand what those who have used (not just read some useless studies) Vytorin are telling you. It simply works better than statins while lowering HDL/LDL ratio very successfully.Now you know where to stick all these charlatanic studies you have been reading !!! Reply
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
Go read the Jupiter Study, then stick Vytorin in the trash!!! ReplyMerck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
If CNBC’s Pharmaceutical Reporter focused less on misguided study or census findings and more on patient/doctor insights he would do himself and his audience a great service.He must be in that ignorant minority who believe that those who are on Vytorin will switch out to other medications because of a botched –up panel discussion !! All the doctors I spoke with are amazed at the media coverage of an isolated and ill-conceived study whose findings, delivered as a monologue, defied all scientific conventions of an interactive panel discussion. As a patient who has tried everything over the last 25 years, I know that Zetia delivers amazing LDL lowering effects and that for patients who need a statin along with Zetia (and there are plenty apparently), nothing beats Vytorin in convenience and economics.
It is about time we start reporting facts and not survey resullts of projected intentions bordering on fiction.
Reply
Merck, Schering-Plough: Confessions of a Vytorin Patient [view article]
What this trial shows is that having a LDL level of 193 or 141 (down from 320) makes no difference with respect to your chances of getting a CVD or increased IMT. This calls into question the reliability of LDL as an indicator of CVD risk. Ergo, it indicates that it makes no sense to try to lower it, because if LDL is not an indicator, it can even less be the *cause* of CVD.If previous trials showed a relationship between LDL level and CVD risk, this trial clearly contradicts them. The scientific method requires for the previous trials to be reviewed very thoroughly, and for new, more sophisticated, higher resolution trials to be carried out if no flaws can be found in the old trials nor in this one. Saying that if Vytorin does not work we should go back to Zocor is not science, it is not medicine but thaumaturgy. Reply
Jim Cramer's Mad Money Lightning Round, 4/10/08: Yahoo a Done Deal [view article]
jim picks are great ReplyPreparing for Dow 30 Earnings [view article]
Great stuff... I'll keep this chart as my desktop just so I can compare it as earnings come through ...Thx jegan ;-) Reply
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
MOMMA..that is a dumb post. The study looked at 15,000 people who" LDL was alreday below 130. No high blood pressure or diabetics. These pts would NOT be considered for Chol. Drug thearpy. Half had CRP greater than 2, and half had lower than 2. If you don't know what CRP is look it up stupid. Those who had high CRP benefited from Crestor, less CV incidents, strokes, etc. IN fact the study was so good halted it after only 2 years. So do me a favor and read the comics you jerk! ReplyMerck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
if crestor couldn't beat PLACEBO it would have real problems! ReplyMerck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
This study is a joke, Steve Nissen hates Merck and was upset he was passed over for leading the study. I heard someone say we need to go back to statins w/ outcome studies, isn't zocor a statin with outcomes??I have been on Vytorin for 12 months, the lower dose and my LDL is around 100. I was on straight zocor 20 before and was only doing ok. The media needs to back off and let doctors make decisions for their individual patients. I thought Crestor (at high doses) had side effects also but now it's a wonder drug???
I don't beleive anything from the media or big pharma in general...it's a business and the doctors are getting paid off all the time for speaking, free lunches, trips, etc...by ALL the companies. Reply
ahead
Preparing for Dow 30 Earnings [view article]
good stats. Thanks ReplyMerck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
That "survey" of 101 PCPs was done by a marketing PR firm. I'm sure it was completely without bias.... ReplyMerck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [view article]
My doctor switched my prescription to Vytorin 2 1/2 years ago after having been on Zocor for 2 years prior. With maintaining the same diet, my cholesterol went down an additional 10%.I have refilled my Vytorin prescription for April and my doctor has no plans to switch to another statin at this time. Reply
10 Pharmaceutical Stocks and Their Patent Expiration Drugs [view article]
your post would be more useful if you highlighted the fraction of cash flow that the expirations will have on an individual company basis. Just giving us drug names is nice, but practically useless.Reply